NHS National Generic Pharmaceuticals Wave 14a

A Contract Award Notice
by NHS ENGLAND

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£562M
Sector
HEALTH
Published
18 Jan 2023
Delivery
01 Feb 2023 to 31 Jan 2025
Deadline
18 Oct 2022 12:00

Concepts

Location

Geochart for 1 buyers and 99 suppliers
NHS England
Sandoz
Amarox
Synchrony
Mylan
Lupin Healthcare
Torbay Pharmaceuticals
Lucane Pharma
Celix Pharma
Fresenius Kabi
Milpharm
Medac Pharma
Teva
Sun Pharma
Wockhardt
Morningside Pharmaeuticals
Neon Healthcare
Flexipharm Austrading
Martindale Pharma
Gerot Lannach
Roche Products
Thornton & Ross
Aventis Pharma
Kent Pharma
Flynn Pharma
CST Pharma
Intrapharm Laboratories
B Braun Medical
Glenmark Pharmaceuticals Europe
Ennogen Healthcare
Desitin Pharma
Cipla
Thea Pharmaceuticals
Baxter Healthcare
Rovi Biotech
Stirling Anglian Pharmaceuticals
Aguettant
Drreddys Laboratories
Tillomed Laboratories
Aspire Pharma
Macleods Pharma
Panpharma
Janssen Cilag
Crescent Pharma
Agb Pharma
MSN Laboratories Europe
Aop Orphan
Consilient Health
Hameln Pharma
Recordati Pharmaceuticals
Brown & Burk
Accord
Arcadia Pharma
Lipomed
Mip Pharma
Bowmed Ibisqus
Sobi Swedish Orphan Biovitrum
Ferring Pharmaceuticals
Bausch Lomb Pharma
Neuraxpharm
Correvio
Manx Healthcare
GH Pharma
Vantage Pharmaceuticals
Laboratorio Reig Jofre
Drugsrus
Otsuka Pharmaceuticals
Waverley Pharma Europe
Tetris Pharma
Alturix
Beaumont Pharma
Phoenix Lab
Bristol Myers Squibb
RPH Pharmaceuticals
PM Pharma
Kensington Pharma
Torrent Pharma
Leaflet | Map tiles by Stamen Design, under CC BY 3.0. Data by OpenStreetMap, under ODbL.

1 buyer

99 suppliers

Description

Invitation to offer for NHS National Generic Pharmaceuticals Wave 14a Offer reference number: CM/PHG/22/5657 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement: Hospital Only Products: DLN & DNW 01/02/2023 - 31/01/2025 (24 Months) Housekeeping Products (Hospital Only): CESW 01/02/2023 - 30/09/2023 (8 Months) LSNE 01/02/2023 - 31/05/2024 (16 Months)

Award Detail

1 Sandoz (Camberley)
  • Value: £207,982,407
2 Amarox (Harrow)
  • Value: £207,982,407
3 Synchrony (Stevenage)
  • Value: £207,982,407
4 Mylan (Potters Bar)
  • Value: £207,982,407
5 Lupin Healthcare (Slough)
  • Value: £207,982,407
6 Torbay Pharmaceuticals (Paignton)
  • Value: £207,982,407
7 Lucane Pharma (Ankeveen)
  • Value: £207,982,407
8 Celix Pharma (London)
  • Value: £207,982,407
9 Fresenius Kabi (Runcorn)
  • Value: £207,982,407
10 Mercury Pharmaceuticals (London)
  • Value: £207,982,407
11 Milpharm (South Ruislip)
  • Value: £207,982,407
12 Glaxosmithkline (London)
  • Value: £207,982,407
13 Medac Pharma (Stirling)
  • Value: £207,982,407
14 Macure Pharma Aps (London)
  • Value: £207,982,407
15 Teva (Castleford)
  • Value: £207,982,407
16 Sun Pharma (Uxbridge)
  • Value: £207,982,407
17 Wockhardt (Wrexham)
  • Value: £207,982,407
18 Morningside Pharmaeuticals (Petersfield)
  • Value: £207,982,407
19 Neon Healthcare (Hertford)
  • Value: £207,982,407
20 Flexipharm Austrading (Bourne End)
  • Value: £207,982,407
21 Martindale Pharma (Romford)
  • Value: £207,982,407
22 Gerot Lannach (Ely)
  • Value: £207,982,407
23 Roche Products (Welwyn Garden City)
  • Value: £207,982,407
24 Thornton & Ross (Linthwaite)
  • Value: £207,982,407
25 Aventis Pharma (Reading)
  • Value: £207,982,407
26 Pierre Fabre (London)
  • Value: £207,982,407
27 Kent Pharma (Ashford)
  • Value: £207,982,407
28 Flynn Pharma (None)
  • Value: £207,982,407
29 Zentiva Pharma (London)
  • Value: £207,982,407
30 CST Pharma (Walsall)
  • Value: £207,982,407
31 Intrapharm Laboratories (Maidenhead)
  • Value: £207,982,407
32 B Braun Medical (Sheffield)
  • Value: £207,982,407
33 Glenmark Pharmaceuticals Europe (Watford)
  • Value: £207,982,407
34 Ennogen Healthcare (Dartford)
  • Value: £207,982,407
35 Desitin Pharma (Woking)
  • Value: £207,982,407
36 Cipla (Addlestone)
  • Value: £207,982,407
37 Thea Pharmaceuticals (Newcastle under Lyme)
  • Value: £207,982,407
38 Pfizer (None)
  • Value: £207,982,407
39 Selective Supplies (London)
  • Value: £207,982,407
40 Baxter Healthcare (Thetford)
  • Value: £207,982,407
41 Rovi Biotech (Croydon)
  • Value: £207,982,407
42 Stirling Anglian Pharmaceuticals (Glasgow)
  • Value: £207,982,407
43 Aguettant (Bristol)
  • Value: £207,982,407
44 Drreddys Laboratories (Milton)
  • Value: £207,982,407
45 Tillomed Laboratories (Luton)
  • Value: £207,982,407
46 Aspire Pharma (Godalming)
  • Value: £207,982,407
47 Macleods Pharma (Billingham)
  • Value: £207,982,407
48 Panpharma (Southport)
  • Value: £207,982,407
49 Janssen Cilag (High Wycombe)
  • Value: £207,982,407
50 Lundbeck (Watford)
  • Value: £207,982,407
51 Colonis Pharma (London)
  • Value: £207,982,407
52 Crescent Pharma (Basingstoke)
  • Value: £207,982,407
53 Aspen Pharmacare (London)
  • Value: £207,982,407
54 Agb Pharma (Lund)
  • Value: £207,982,407
55 Seacross Pharmaceuticals (London)
  • Value: £207,982,407
56 MSN Laboratories Europe (Hitchin)
  • Value: £207,982,407
57 Aop Orphan (Birmingham)
  • Value: £207,982,407
58 Consilient Health (Richmond upon Thames)
  • Value: £207,982,407
59 Hameln Pharma (Gloucester)
  • Value: £207,982,407
60 Biocon (London)
  • Value: £207,982,407
61 Day Lewis Medical (Croydon)
  • Value: £207,982,407
62 Recordati Pharmaceuticals (Bracknell)
  • Value: £207,982,407
63 Brown & Burk (Hounslow)
  • Value: £207,982,407
64 Accord (Barnstaple)
  • Value: £207,982,407
65 Arcadia Pharma (Swansea)
  • Value: £207,982,407
66 Lipomed (Weil am Rhein)
  • Value: £207,982,407
67 Mip Pharma (Blieskastel Niederwuerzbach Germany)
  • Value: £207,982,407
68 Bowmed Ibisqus (Manchester)
  • Value: £207,982,407
69 Sobi Swedish Orphan Biovitrum (Abington)
  • Value: £207,982,407
70 Ferring Pharmaceuticals (West Drayton)
  • Value: £207,982,407
71 Bausch Lomb Pharma (Kingston upon Thames)
  • Value: £207,982,407
72 Neuraxpharm (Cardiff)
  • Value: £207,982,407
73 Correvio (Bielefeld Germany)
  • Value: £207,982,407
74 Manx Healthcare (Warwick)
  • Value: £207,982,407
75 GH Pharma (Dover)
  • Value: £207,982,407
76 Piramal Critical Care (West Drayton)
  • Value: £207,982,407
77 Waymade (London)
  • Value: £207,982,407
78 Pari (London)
  • Value: £207,982,407
79 Vantage Pharmaceuticals (Hemel Hempstead)
  • Value: £207,982,407
80 Aristo Pharma (Ely)
  • Value: £207,982,407
81 Laboratorio Reig Jofre (Bideford)
  • Value: £207,982,407
82 Drugsrus (Northwood)
  • Value: £207,982,407
83 Chiesi (Manchester)
  • Value: £207,982,407
84 Otsuka Pharmaceuticals (Wexham)
  • Value: £207,982,407
85 Takeda (London)
  • Value: £207,982,407
86 Waverley Pharma Europe (None)
  • Value: £207,982,407
87 Tetris Pharma (Marlow)
  • Value: £207,982,407
88 Ascend Laboratories (London)
  • Value: £207,982,407
89 Alturix (Milton Keynes)
  • Value: £207,982,407
90 Beaumont Pharma (Burnley)
  • Value: £207,982,407
91 Phoenix Lab (Clonee)
  • Value: £207,982,407
92 Focus Pharmaceuticals (London)
  • Value: £207,982,407
93 Bristol Myers Squibb (Denham)
  • Value: £207,982,407
94 RPH Pharmaceuticals (Cheadle)
  • Value: £207,982,407
95 PM Pharma (Norwich)
  • Value: £207,982,407
96 Kensington Pharma (Preston)
  • Value: £207,982,407
97 Strides Pharma (Watford)
  • Value: £207,982,407
98 Logixx Pharma (Reading)
  • Value: £207,982,407
99 Torrent Pharma (Crawley)
  • Value: £207,982,407

CPV Codes

  • 33600000 - Pharmaceutical products

Indicators

  • Contract is suitable for SMEs.

Other Information

CM_PHG_22_5657_03 - Wave 14a Transparency Award Schedules CM_PHG_22_5657_03 - Wave 14a Transparency Award Schedules.pdf CM_PHG_22_5657_02 - Wave 14a Transparency Award Schedules CM_PHG_22_5657_02 - Wave 14a Transparency Award Schedules.pdf

Reference

Domains